Syncom Formulations (India) Ltd Surges in Stock Market, Hits New Highs

Sep 06 2024 09:35 AM IST
share
Share Via
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been performing exceptionally well in the stock market. Its stock has gained 7.34% on September 6th and has consistently risen for the last 3 days, reaching a new 52-week and all-time high. With a 'Buy' call from MarketsMojo and strong investor confidence, the company is expected to continue its upward momentum and deliver returns for its investors.

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 6th, the company's stock gained 7.34%, outperforming the sector by 7.41%. This positive trend has been consistent for the last 3 days, with the stock rising 19.93% in that period.

The company's stock has also hit a new 52-week and all-time high of Rs.23.99, which is a significant milestone for the company. This strong performance has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock.

Intraday trading saw the stock reach a high of Rs.23.99, a 7.97% increase from the previous day. This is a clear indication of the company's upward momentum and investor confidence.

Syncom Formulations (India) Ltd is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for the company's future.

In comparison to the Sensex, Syncom Formulations (India) Ltd has outperformed with a 1-day performance of 7.83% and a 1-month performance of 56.50%. This shows the company's strong growth potential and its ability to deliver returns for its investors.

With its recent performance and positive outlook, Syncom Formulations (India) Ltd is definitely a stock to watch out for in the pharmaceutical industry. Investors can expect continued growth and success from this smallcap company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Dec 18 2025 01:02 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via
Most Read
Kanani Industries Ltd is Rated Strong Sell
45 minutes ago
share
Share Via
Shiva Texyarn Ltd is Rated Sell
45 minutes ago
share
Share Via
Riba Textiles Ltd is Rated Sell
45 minutes ago
share
Share Via
Piramal Pharma Ltd is Rated Strong Sell
45 minutes ago
share
Share Via
Infibeam Avenues Ltd is Rated Hold
45 minutes ago
share
Share Via